AI주식인사이트AI Stock Insight
C

CJ 바이오사이언스

311690KOSDAQ

49.0 / 100

Reference Date: 2026-10-23

Financial Score18.5 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 6.5% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

CJ BioScience operates core businesses including AI-powered microbiome analysis platforms (Ez-Mx®) for drug development, microbial genome analysis solutions, and health & wellness services (e.g., GUT INSIDE, SMILE GUT). The company has strategically shifted focus toward health & wellness, expanding consumer-accessible AI-based gut health diagnostic services in 2025. The majority of revenue comes from its microbiome genome analysis platform, EzBioCloud.

Number of Employees

102people

Average Salary

79.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.94Industry Average 1.204.0Point

In line with industry avg

ROE
-36.54Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
7.72Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼15.7% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲10.4% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -39.5% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (10%, downtrend)

Current 3,870Won52-week high 9,92052-week low 3,185
1-month return4.0Point

1m +6.46% (slight rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0